MPV_ICSH International Case Studies in Healthcare

Faculty of Economics and Administration
Spring 2025

The course is not taught in Spring 2025

Extent and Intensity
0/2/0. 4 credit(s). Type of Completion: z (credit).
In-person direct teaching
Teacher(s)
PharmDr. Martin Višňanský, MBA, Ph.D. (seminar tutor)
Guaranteed by
PharmDr. Martin Višňanský, MBA, Ph.D.
Department of Public Economics – Faculty of Economics and Administration
Contact Person: Jana Biskupová
Supplier department: Department of Public Economics – Faculty of Economics and Administration
Prerequisites
No specific prerequisites and/or co-requisites.
Course Enrolment Limitations
The course is only offered to the students of the study fields the course is directly associated with.
fields of study / plans the course is directly associated with
Course objectives
The aim of the subject is to present and discuss real-life, specific cases on HTA from well-defined and precisely selected stakeholders and resources, e.g. NICE, EUnetHTA Databases, Value in Health, Int J TA in HC, etc.
Students will gain broader knowledge on the process of assessment and appraisal of selected technologies in healthcare, based on the EUnetHTA Core Model and EUnetHTA / EMA join assessment procedure as well as capacity building and assessment.
Individual Stakeholders’ engagement and advocacy groups impact will be discussed in order to understand and anticipate the importance of formal regulatory framework as well as informal forces on utilization of value in healthcare and perception of value innovation in health technologies across all domains of HTA within EUnetHTA Core Model Concept.
Learning outcomes
Completing the course, the student will gain deeper understanding and practical knowledge on different approaches towards Health Technology Assessment and Appraisal, with focus on EUnetHTA Core Model Process of Assessment and Appraisal as well as EUnetHTA / EMA Join assessment procedure. They will understand the roles, motivators and setbacks of different stakeholders (e.g. producers, regulators, payers, healthcare professionals, patients and patient advocacy groups, caregivers, health policy makers) in a process of value creation and utilization in healthcare for various products, services and technologies.
Syllabus
  • Selected Cases and methodologies from several resources as follows:
  • - EUnetHTA initiatives (JA1, JA2 and Collaboration);
  • - EUnetHTA Core Model;
  • - HTA Methodologies across the Globe (HTAi, INAHTA), EUnetHTA / EMA join assessment;
  • - Stakeholders Engagement;
  • - Patient Advocacy Groups and their interactions across and within the Healthcare Systems; EUPATI and European Patient Forum;
  • - EURORDIS and ORPHANET;
  • - CADTH and its specificities / soft-domains of HTA;
  • - NICE and SMC;
  • - G-BA and IQWiG;
  • - HAS and AIFA,
  • - HTA in Central & Eastern Europe;
  • - HTA in selected Asia-Pacific Regions; Global HTA initiatives.
Literature
    recommended literature
  • Value in Health, ISPOR.
  • International Journal of Technology Assessment in Healthcare, Cambridge University Press and HTAi.
    not specified
  • Pharmacoeconomics :principles and practice. Edited by Lorenzo Pradelli - Albert Wertheimer. First edition. 1 online r. ISBN 9788897419389. info
  • J. Lyle Bootman. Principles of Pharmacoeconomics. info
  • Rascati, L. Karen. Essentials of Pharmacoeconomics. Philadelphia: Wolters Kluwer Health/Lippincott W, 2014. ISBN 978-1451175936. info
Teaching methods
Monological, Dialogic (discussion, interview, brainstorming) Workshops, Individual and Group Assignment / Presentations
Assessment methods
one individual and one group project assignment presentation
Language of instruction
English
Further Comments
The course is taught annually.
The course is taught: every week.
  • Permalink: https://is.muni.cz/course/econ/spring2025/MPV_ICSH